Filing Flows › Orthopediatrics (KIDS) › Q3 2026
Orthopediatrics (KIDS) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 28, 2026
Orthopediatrics (KIDS) reported revenue of $72.7M for the third quarter 2026 (Q3 2026), +19% from a year earlier and +3% from the quarter before. Operating margin was -5.8%, net loss $5.9M (8.2% of revenue).
Orthopediatrics, Q3 2026: revenue $72.7M (+19% year over year), operating margin -5.8%, net loss $5.9M, operating cash flow $4.5M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $72.7M | +3% | +19% |
| Operating profit | −$4.2M | — | — |
| Net earnings | −$5.9M | — | — |
| Operating cash flow | $4.5M | +386% | — |
| Free cash flow | $1.6M | — | — |
What changed
Revenue was $72.7M in Q3 2026, up 19% year over year and up 3% from the previous quarter. Trauma and deformity was the largest line at 72% of revenue. Trauma and deformity added $8.5M year over year (up 19%), 74% of the total change.
Gross margin was 74.3%, up 0.4 points from Q3 2025. Operating costs exceeded revenue by $4.2M, an operating margin of -5.8%. Operating expenses grew 6% against revenue growth of 19%. The fastest-growing cost line was Sales & marketing (+24%). The quarter ended with a net loss of $5.9M, narrower than the previous quarter's $7.2M loss.
Operating cash flow was $4.5M. Non-cash charges added back $5.6M of depreciation and amortization and $4.4M of share-based compensation. Working capital and other items added $396K. Capital expenditures of $2.9M left free cash flow of $1.6M.
Questions
What was Orthopediatrics' revenue in the third quarter 2026?
Orthopediatrics (KIDS) reported revenue of $72.7M for the third quarter 2026 (Q3 2026), +19% from a year earlier and +3% from the quarter before.
Was Orthopediatrics profitable in the third quarter 2026?
Operating loss was $4.2M (-5.8% of revenue) and net loss $5.9M.
Source: Orthopediatrics 10-Q on SEC EDGAR.